News

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

After years of life-threatening cardiac episodes and chest pain, Cindy Mager, 59, became the first Saint Luke's patient to undergo this innovative, life-saving procedure.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

One patient's experience more than a decade ago was a pivotal moment for both Saint Luke’s Mid America Heart Institute and Saint Luke's Hospital Maternal-Fetal Medicine Program.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.